W.H. Cornerstone Investments’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$576K Buy
626
+1
+0.2% +$1.01K 0.36% 54
2025
Q4
$672K Buy
625
+1
+0.2% +$956 0.4% 55
2025
Q3
$476K Buy
624
+1
+0.2% +$744 0.29% 72
2025
Q2
$485K Sell
623
-99
-14% -$76.9K 0.31% 72
2025
Q1
$597K Sell
722
-60
-8% -$49.9K 0.41% 61
2024
Q4
$604K Sell
782
-277
-26% -$229K 0.4% 61
2024
Q3
$938K Sell
1,059
-254
-19% -$228K 0.63% 38
2024
Q2
$1.19M Buy
1,313
+100
+8% +$80K 0.84% 25
2024
Q1
$944K Buy
1,213
+374
+45% +$266K 0.68% 40
2023
Q4
$489K Buy
839
+2
+0.2% +$1.17K 0.39% 74
2023
Q3
$450K Buy
837
+2
+0.2% +$1.03K 0.4% 70
2023
Q2
$392K Buy
835
+2
+0.2% +$839 0.35% 71
2023
Q1
$286K Buy
833
+3
+0.4% +$1.01K 0.26% 91
2022
Q4
$300K Buy
830
+2
+0.2% +$709 0.29% 85
2022
Q3
$271K Buy
+828
New +$262K 0.29% 88

Other funds holding LLY

W.H. Cornerstone Investments's LLY Position: Q1 2026 in Review

W.H. Cornerstone Investments increased its Eli Lilly (LLY) stake by 0.16% in Q1 2026, buying an estimated $1.01K and bringing the position to 626 shares worth $576K. The position accounts for 0.36% of the portfolio, ranked #54.

W.H. Cornerstone Investments first reported a position in LLY in Q3 2022 and has held it in 15 quarters since. The position peaked at $1.19M in Q2 2024. 4,354 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

  • W.H. Cornerstone Investments held 626 shares of Eli Lilly worth $576K as of Q1 2026.
  • W.H. Cornerstone Investments bought 1 Eli Lilly share in Q1 2026, an estimated $1.01K.
  • Eli Lilly made up 0.36% of W.H. Cornerstone Investments's portfolio in Q1 2026, its #54 holding.
  • W.H. Cornerstone Investments first reported a position in Eli Lilly in Q3 2022 and has held it in 15 quarters since.
  • W.H. Cornerstone Investments's Eli Lilly position peaked at $1.19M in Q2 2024.
  • 4,354 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on W.H. Cornerstone Investments's 13F filing for Q1 2026, filed 28 Apr 2026.